PERMAFIX MEDICAL

Perma-Fix Medical has developed a breakthrough proprietary process that can be manufactured to support the worldwide shortage of Tc-99m in nuclear medicine. The main shareholder of Perma-Fix Medical is Perma-Fix Environmental Services, Inc., a nuclear services company and leading provider of nuclear and mixed waste management services. Nuclear Medicine uses radiation to provide diagnostic information about the functioning of specific organs, and radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. Tens of millions of nuclear procedures are performed each year driving the demand for radioisotopes. The Perma-Fix Medical solution meets US and global market supply needs for Tc-99m without the use of foreign suppliers of Highly Enriched Uranium (HEU) or Low Enriched Uranium (LEU) targets. In addition, it eliminates environmental concerns associated with the current Mo-99 production methodology,..

Also known as: Perma-Fix, Perma-Fix Environmental Services Inc., Perma-Fix Medical S.A